Literature DB >> 22987310

The origin and arrhythmogenic potential of fibroblasts in cardiac disease.

Carolina Vasquez1, Gregory E Morley.   

Abstract

Fibroblasts play a major role in normal cardiac physiology and in the response of the heart to injury and disease. Cardiac electrophysiological research has primarily focused on the mechanisms of remodeling that accompany cardiac disease with an emphasis on myocyte electrophysiology. Recently, there has been increasing interest in the potential role of fibroblasts in cardiac electrophysiology. This review focuses on the arrhythmia mechanisms involving interactions between myocytes and fibroblasts. We also discuss the available evidence supporting the contribution of intracardiac and extracardiac sources to the fibroblast and myofibroblast populations in diseased hearts.

Entities:  

Mesh:

Year:  2012        PMID: 22987310      PMCID: PMC3666853          DOI: 10.1007/s12265-012-9408-1

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  83 in total

Review 1.  Myofibroblasts. I. Paracrine cells important in health and disease.

Authors:  D W Powell; R C Mifflin; J D Valentich; S E Crowe; J I Saada; A B West
Journal:  Am J Physiol       Date:  1999-07

2.  Comparison of infarct-derived and control ovine cardiac myofibroblasts in culture: response to cytokines and natriuretic peptide receptor expression profiles.

Authors:  Martin D Jarvis; Miriam T Rademaker; Leigh J Ellmers; Margaret J Currie; Judith L McKenzie; Barry R Palmer; Christopher M Frampton; A Mark Richards; Vicky A Cameron
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-10       Impact factor: 4.733

3.  Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction.

Authors:  M J van Amerongen; G Bou-Gharios; Er Popa; J van Ark; A H Petersen; G M van Dam; M J A van Luyn; M C Harmsen
Journal:  J Pathol       Date:  2008-02       Impact factor: 7.996

4.  Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers.

Authors:  Sharon Zlochiver; Viviana Muñoz; Karen L Vikstrom; Steven M Taffet; Omer Berenfeld; José Jalife
Journal:  Biophys J       Date:  2008-07-25       Impact factor: 4.033

5.  Myofibroblasts and smooth muscle cells in human myocardial scars: Possible origins and inductive factors.

Authors:  R Vracko; D Thorning
Journal:  Cardiovasc Pathol       Date:  2004-04-22       Impact factor: 2.185

Review 6.  Molecular regulation of atrioventricular valvuloseptal morphogenesis.

Authors:  L M Eisenberg; R R Markwald
Journal:  Circ Res       Date:  1995-07       Impact factor: 17.367

Review 7.  Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis.

Authors:  K M Fries; T Blieden; R J Looney; G D Sempowski; M R Silvera; R A Willis; R P Phipps
Journal:  Clin Immunol Immunopathol       Date:  1994-09

8.  Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution.

Authors:  A C Nag
Journal:  Cytobios       Date:  1980

Review 9.  Origins of cardiac fibroblasts.

Authors:  Elisabeth M Zeisberg; Raghu Kalluri
Journal:  Circ Res       Date:  2010-11-26       Impact factor: 17.367

10.  Adult mouse epicardium modulates myocardial injury by secreting paracrine factors.

Authors:  Bin Zhou; Leah B Honor; Huamei He; Qing Ma; Jin-Hee Oh; Catherine Butterfield; Ruei-Zeng Lin; Juan M Melero-Martin; Elena Dolmatova; Heather S Duffy; Alexander von Gise; Pingzhu Zhou; Yong Wu Hu; Gang Wang; Bing Zhang; Lianchun Wang; Jennifer L Hall; Marsha A Moses; Francis X McGowan; William T Pu
Journal:  J Clin Invest       Date:  2011-04-18       Impact factor: 14.808

View more
  16 in total

1.  Interleukin-10 Inhibits Bone Marrow Fibroblast Progenitor Cell-Mediated Cardiac Fibrosis in Pressure-Overloaded Myocardium.

Authors:  Suresh K Verma; Venkata N S Garikipati; Prasanna Krishnamurthy; Sarah M Schumacher; Laurel A Grisanti; Maria Cimini; Zhongjian Cheng; Mohsin Khan; Yujia Yue; Cindy Benedict; May M Truongcao; Joseph E Rabinowitz; David A Goukassian; Douglas Tilley; Walter J Koch; Raj Kishore
Journal:  Circulation       Date:  2017-06-30       Impact factor: 29.690

Review 2.  Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.

Authors:  Katherine B Schuetze; Timothy A McKinsey; Carlin S Long
Journal:  J Mol Cell Cardiol       Date:  2014-03-11       Impact factor: 5.000

3.  Inscribing Optical Excitability to Non-Excitable Cardiac Cells: Viral Delivery of Optogenetic Tools in Primary Cardiac Fibroblasts.

Authors:  Jinzhu Yu; Emilia Entcheva
Journal:  Methods Mol Biol       Date:  2016

Review 4.  Fibroblasts in myocardial infarction: a role in inflammation and repair.

Authors:  Arti V Shinde; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2013-12-07       Impact factor: 5.000

Review 5.  Cardiac applications of optogenetics.

Authors:  Christina M Ambrosi; Aleksandra Klimas; Jinzhu Yu; Emilia Entcheva
Journal:  Prog Biophys Mol Biol       Date:  2014-07-15       Impact factor: 3.667

Review 6.  Cardiovascular disease models: A game changing paradigm in drug discovery and screening.

Authors:  Houman Savoji; Mohammad Hossein Mohammadi; Naimeh Rafatian; Masood Khaksar Toroghi; Erika Yan Wang; Yimu Zhao; Anastasia Korolj; Samad Ahadian; Milica Radisic
Journal:  Biomaterials       Date:  2018-10-01       Impact factor: 12.479

Review 7.  Ca2+ signalling in fibroblasts and the therapeutic potential of KCa3.1 channel blockers in fibrotic diseases.

Authors:  Katy M Roach; Peter Bradding
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

Review 8.  The Living Scar--Cardiac Fibroblasts and the Injured Heart.

Authors:  Eva A Rog-Zielinska; Russell A Norris; Peter Kohl; Roger Markwald
Journal:  Trends Mol Med       Date:  2016-01-14       Impact factor: 11.951

Review 9.  Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.

Authors:  Robert G Gourdie; Stefanie Dimmeler; Peter Kohl
Journal:  Nat Rev Drug Discov       Date:  2016-06-24       Impact factor: 84.694

10.  Myocardial fibrosis in congenital and pediatric heart disease.

Authors:  Jing Tian; Xinjiang An; Ling Niu
Journal:  Exp Ther Med       Date:  2017-03-10       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.